Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Completed 3Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Breast Neoplasms 8Rectal Neoplasms 5Lung Neoplasms 4Esophageal Neoplasms 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Adenocarcinoma Of Esophagus 4Colonic Neoplasms 3Central Nervous System Neoplasms 3Breast Neoplasms, Male 3Brain Neoplasms 3Sarcoma 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Osteosarcoma 2Lymphoma 2Head and Neck Neoplasms 2Glioblastoma 2Breast Carcinoma In Situ 2Vomiting 1Teratoma 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Peritoneal Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasm Metastasis 1Nausea 1Medulloblastoma 1

Interventions

Radiotherapy 22Fluorouracil 20Oxaliplatin 19Leucovorin 14Cisplatin 14Paclitaxel 10Radiation 8Irinotecan 8Docetaxel 7Capecitabine 7Cetuximab 6Carboplatin 6pembrolizumab 5Neoadjuvant Therapy 5Trastuzumab 4Taxes 4Chemotherapy, Adjuvant 4Panitumumab 3Microarray Analysis 3Immunohistochemistry 3Folfox protocol 3Epirubicin 3Biopsy 3tucatinib 2Surgical Procedures, Operative 2Reverse Transcriptase Polymerase Chain Reaction 2Magnetic Resonance Spectroscopy 2Gene Expression Profiling 2Gefitinib 2Everolimus 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has results × Adenocarcinoma Of Esophagus × Chemotherapy, Adjuvant × Clear all
NCT00601705 2019-04-30

Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach

Case Comprehensive Cancer Center

Phase 2 Completed
61 enrolled 12 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT00493025 2018-12-06

Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
19 enrolled 4 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT00354679 2016-05-16

Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
34 enrolled 5 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT00470184 2013-11-25

Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer

Roswell Park Cancer Institute

Phase 2 Completed
41 enrolled 8 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡